ImmPACT Bio USA
ImmPACT Bio USA is developing novel therapies that will improve current T-cell therapy by addressing the need to differentiate cancerous from non-cancerous tissues to increase safety and effectiveness. Read More
ImmPACT Bio USA is developing novel therapies that will improve current T-cell therapy by addressing the need to differentiate cancerous from non-cancerous tissues to increase safety and effectiveness. Read More
Repl.it is a free, collaborative, browser-based integrated development environment (IDE) tool for starting, sharing, and developing projects, built for cross-platform collaborative coding in 50+ languages. Read More
Toast, Inc. is a technology company which allows restaurants to handle in-person, online, and mobile app payments. They plan to raise $100 million in their upcoming initial public offering (IPO). They filed for their initial public offering last Friday with the SEC and could end up with a … Read More
U.S. small businesses are still able to apply for the federal pandemic stimulus program. According to SBA Administrator, Isabella Casillas Guzman, “We still have billions of dollars in relief in our COVID idle program.” Guzman served as the Director of the California Office of the Small Business Advocate before … Read More
What are MWVBEs? In conjunction with the popular Wall Street underwriters, Goldman Sachs and JPMorgan Chase, 4 minority-owned firms joined the IPO party for the highly anticipated Robinhood public offering that occurred last month. Ramirez & Co. and Siebert Williams Shanks were 2 of the 4 underwriters classified as … Read More
States are Deciding to Lower Taxes As states recover from the pandemic economy, many are looking for ways to improve quality of living and incentivize both taxpayers and businesses to call their state home. Out of the 50, 11 states have already passed legislation to lower state taxes … Read More
Intellimize uses AI to customize and update your website in real time based on the best possible conversion opportunities and to maximize the customer experience for each unique visitor. Read More
Cardea is developing a new generation of (bio)technology infrastructure that can be directly integrated into modern electronics so that we can have products that utilize system biology’s vast range of live signals as interactive data-streams. Read More